FDA-Drug2026-03-11Class IIPROCESSING DEFECT
New Life Pharma Nomida semaglutide injection recalled for sterility concerns
What this means
New Life Pharma is recalling Nomida semaglutide 2 mg injection vials because the sterility of the product cannot be assured. The affected vials may not be safe to use. This recall affects a limited quantity distributed in Ohio.
- Stop using the recalled semaglutide vials immediately
- Check if you have lot 240903 (expiration 9/30/2026)
- Contact your pharmacy or doctor for a replacement or alternative medication
- Do not inject any doses from affected vials
The agency's original wording
Hazard
Lack of Assurance of Sterility
Intended for
Adults
Illnesses reported
None reported
Sold states
OH
Affected count
2 vials
Manufactured in
265 Livingston St, N/A, Northvale, NJ, United States
Products
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0393-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.